EN
Therapeutic Areas
Calyxha Biotechnologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CAL-4 | Asthma | Preclinical |
Leadership Team at Calyxha Biotechnologies
PR
Prof. Robert Konrat, PhD
Co-founder and CSO
MW
Mag. Wolfgang Friedl
Co-founder, Acting COO
PA
Patrick Aisher
Investment Advisor